Zepp Health Net Worth

Zepp Health Net Worth Breakdown

  ZEPP
The net worth of Zepp Health Corp is the difference between its total assets and liabilities. Zepp Health's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Zepp Health's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Zepp Health's net worth can be used as a measure of its financial health and stability which can help investors to decide if Zepp Health is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Zepp Health Corp stock.

Zepp Health Net Worth Analysis

Zepp Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Zepp Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Zepp Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Zepp Health's net worth analysis. One common approach is to calculate Zepp Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Zepp Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Zepp Health's net worth. This approach calculates the present value of Zepp Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Zepp Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Zepp Health's net worth. This involves comparing Zepp Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Zepp Health's net worth relative to its peers.

Enterprise Value

2.74 Billion

To determine if Zepp Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Zepp Health's net worth research are outlined below:
Zepp Health Corp is way too risky over 90 days horizon
Zepp Health Corp appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 182.6 M. Net Loss for the year was (75.81 M) with profit before overhead, payroll, taxes, and interest of 69.89 M.
Zepp Health Corp currently holds about 996.59 M in cash with (24.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 16.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from gurufocus.com: NFL Running Back Derrick Henry Joins Amazfit as Athlete Ambassador ZEPP Stock News

Zepp Health Quarterly Good Will

9.58 Million

Zepp Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Zepp Health Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Zepp Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
19th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Zepp Health Target Price Consensus

Zepp target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Zepp Health's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   One  Strong Buy
Most Zepp analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Zepp stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Zepp Health Corp, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Zepp Health Target Price Projection

Zepp Health's current and average target prices are 13.04 and 12.32, respectively. The current price of Zepp Health is the price at which Zepp Health Corp is currently trading. On the other hand, Zepp Health's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Zepp Health Market Quote on 21st of July 2025

Low Price12.61Odds
High Price14.19Odds

13.04

Target Price

Analyst Consensus On Zepp Health Target Price

Low Estimate11.21Odds
High Estimate13.68Odds

12.32

Historical Lowest Forecast  11.21 Target Price  12.32 Highest Forecast  13.68
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Zepp Health Corp and the information provided on this page.

Know Zepp Health's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Zepp Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zepp Health Corp backward and forwards among themselves. Zepp Health's institutional investor refers to the entity that pools money to purchase Zepp Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Rialto Wealth Management, Llc2025-03-31
1000
Sbi Securities Co Ltd2025-03-31
941
Advisor Group Holdings, Inc.2025-03-31
575
Rhumbline Advisers2025-03-31
529
Jpmorgan Chase & Co2025-03-31
236
Lazard Asset Management Llc2025-03-31
157
Royal Bank Of Canada2024-12-31
100.0
Bank Of America Corp2025-03-31
62.0
Mccormack Advisors International2025-03-31
53.0
Allspring Global Investments Holdings, Llc2025-03-31
854.3 K
Fidelity International Ltd2025-03-31
719.5 K
Note, although Zepp Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Zepp Health's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 189.52 M.

Market Cap

2.68 Billion

Project Zepp Health's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.15)(0.14)
Return On Capital Employed(0.14)(0.13)
Return On Assets(0.14)(0.14)
Return On Equity(0.30)(0.29)
The company has Profit Margin (PM) of (0.45) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.48) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.48.
When accessing Zepp Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Zepp Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Zepp Health's profitability and make more informed investment decisions.

Evaluate Zepp Health's management efficiency

Zepp Health Corp has return on total asset (ROA) of (0.0565) % which means that it has lost $0.0565 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2856) %, meaning that it created substantial loss on money invested by shareholders. Zepp Health's management efficiency ratios could be used to measure how well Zepp Health manages its routine affairs as well as how well it operates its assets and liabilities. As of 07/21/2025, Return On Tangible Assets is likely to grow to -0.14. In addition to that, Return On Capital Employed is likely to grow to -0.13. As of 07/21/2025, Total Current Liabilities is likely to drop to about 185.6 M. In addition to that, Liabilities And Stockholders Equity is likely to drop to about 502.2 M
Last ReportedProjected for Next Year
Book Value Per Share 15.62  18.62 
Tangible Book Value Per Share 14.59  17.51 
Enterprise Value Over EBITDA(2.81)(2.67)
Price Book Value Ratio 0.04  0.04 
Enterprise Value Multiple(2.15)(2.04)
Price Fair Value 0.04  0.04 
Enterprise Value2.9 B2.7 B
Effective leadership at Zepp Health drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Enterprise Value Revenue
1.6436
Revenue
181.2 M
Quarterly Revenue Growth
(0.03)
Revenue Per Share
11.232
Return On Equity
(0.29)

Zepp Health Corporate Filings

18th of July 2025
Other Reports
ViewVerify
14th of July 2025
Other Reports
ViewVerify
21st of May 2025
Other Reports
ViewVerify
6K
20th of May 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
Zepp Health time-series forecasting models is one of many Zepp Health's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Zepp Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Zepp Health Earnings Estimation Breakdown

The calculation of Zepp Health's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Zepp Health is estimated to be -0.035 with the future projection ranging from a low of -0.035 to a high of -0.035. Please be aware that this consensus of annual earnings estimates for Zepp Health Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-2.29
-0.04
Lowest
Expected EPS
-0.035
-0.04
Highest

Zepp Health Earnings Projection Consensus

Suppose the current estimates of Zepp Health's value are higher than the current market price of the Zepp Health stock. In this case, investors may conclude that Zepp Health is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Zepp Health's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2025Current EPS (TTM)
1-1.04%
-2.29
-0.035
-4.96

Zepp Health Earnings per Share Projection vs Actual

Actual Earning per Share of Zepp Health refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Zepp Health Corp predict the company's earnings will be in the future. The higher the earnings per share of Zepp Health, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Zepp Health Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Zepp Health, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Zepp Health should always be considered in relation to other companies to make a more educated investment decision.

Zepp Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Zepp Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-05-20
2025-03-310-1.23-1.23
2025-03-26
2024-12-310.4096-2.29-2.6996659 
2024-11-12
2024-09-300.2985-0.8205-1.119374 
2024-08-21
2024-06-300.04-0.1665-0.2065516 
2024-05-20
2024-03-31-0.03-0.2263-0.1963654 
2024-03-18
2023-12-310.30.06-0.2480 
2023-11-20
2023-09-300.230.05-0.1878 
2023-08-21
2023-06-300.09-0.97-1.061177 
2023-05-23
2023-03-31-0.17-1.84-1.67982 
2023-03-21
2022-12-310.04-0.14-0.18450 
2022-11-21
2022-09-303.86-0.14-4.0103 
2022-08-25
2022-06-30-1.32-1.54-0.2216 
2022-05-24
2022-03-310.391.210.82210 
2022-03-17
2021-12-312.360.79-1.5766 
2021-11-16
2021-09-301.570.98-0.5937 
2021-08-19
2021-06-301.52.010.5134 
2021-05-13
2021-03-310.49-0.46-0.95193 
2021-03-15
2020-12-311.431.960.5337 
2020-11-23
2020-09-302.621.85-0.7729 
2020-08-18
2020-06-300.350.3-0.0514 
2020-05-12
2020-03-311.170.39-0.7866 
2020-03-13
2019-12-313.043.310.27
2019-11-12
2019-09-302.73.250.5520 
2019-08-19
2019-06-301.721.730.01
2019-06-03
2019-03-310.641.490.85132 
2019-03-14
2018-12-311.282.31.0279 
2018-11-26
2018-09-300.390.450.0615 
2018-08-20
2018-06-300.881.610.7382 
2018-05-21
2018-03-310.771.560.79102 
2018-03-27
2017-12-310.921.480.5660 
2017-11-29
2017-09-3000.120.12
2017-05-04
2017-03-310-0.06-0.06

Zepp Health Corporate Management

Xiaojun ZhangVP ResourcesProfile
Hui WangVice President of Corporate Strategy and General Manager of Beijing OperationsProfile
Jimmy LaiIndependent DirectorProfile
Hongjiang ZhangIndependent DirectorProfile
De LiuDirectorProfile

Already Invested in Zepp Health Corp?

The danger of trading Zepp Health Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zepp Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zepp Health. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zepp Health Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

Additional Tools for Zepp Stock Analysis

When running Zepp Health's price analysis, check to measure Zepp Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zepp Health is operating at the current time. Most of Zepp Health's value examination focuses on studying past and present price action to predict the probability of Zepp Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zepp Health's price. Additionally, you may evaluate how the addition of Zepp Health to your portfolios can decrease your overall portfolio volatility.